NEW YORK, June 26 (GenomeWeb News) - OncoMethylome Sciences has priced its initial public offering at €7.50 ($9.44) per share and will begin trading on the Eurolist exchange in Brussels and Amsterdam tomorrow, the company said today.
The company said that it expects to raise €22 million ($27.7 million) by issuing 2,933,334 new shares. It could raise up to €25 million if a 15 percent over-allotment option is exercised in full.
Approximately 12 percent of the shares will be allocated to retail investors in
OncoMethylome Sciences, which is developing diagnostics based on DNA methylation patterns, will be listed under the ticker symbol ONCOB by Euronext Brussels and under the ticker symbol ONCOA by Euronext Amsterdam.
The company is based in